newsfilter
← Latest News
GlobeNewswire·

Flexion Therapeutics Reports First-Quarter 2021 Financial Results and Recent Business Updates

Flexion reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $24.6 million David Arkowitz, CFO, stepping down effective May 31,2021, and will be succeeded by Fred Driscoll New data presented at ASGCT ind